Cherng-Chyi Tzeng
Kaohsiung Medical University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Cherng-Chyi Tzeng.
Bioorganic & Medicinal Chemistry | 2006
Chih-Hua Tseng; Yeh-Long Chen; Pei Jung Lu; Chia-Ning Yang; Cherng-Chyi Tzeng
Although the quinoline ring is found in a wide variety of biologically active compounds and is frequently condensed with various heterocycles, synthesis and biological evaluation of the indenoquinoline skeleton attracts only very limited attention. We report herein the synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives against the growth of six cancer cell lines including human cervical epithelioid carcinoma (HeLa), oral squamous cell carcinoma (SAS), hepatocellular carcinoma (SKHep), human stomach adenocarcinoma (AGS), prostate cancer (PC-3), and non-small cell lung cancer (A549). The results indicated that 9-methoxy-6-(piperazin-1-yl)-11H-indeno[1,2-c]quinolin-11-one (17b) is more active than its C(6)-amino derivative 17a, C(6)-morpholine and C(6)-piperidine isomers, 17c and 17d, respectively. Treatment of 17b with NH(2)OH afforded its hydroxyimino derivative 20 which is more active than the carbonyl precursor 17b. More potent agents were obtained by further derivatization of 20. Thus, antiproliferative activities decreased in an order of aminoalkoxyimino 22a-d>hydroxyimino 20>alkoxyimino 21, 22e>carbonyl 17b. Both AGS and A549 were resistant to camptothecin with GI(50) values of 23.76 and 2.80 microM, respectively, while GI(50) values for 22a-d were in the range of 5.93-7.11 microM and 0.38-0.87 microM, respectively. Among them, 22b was the most potent with GI(50) values of 0.52, 0.74, 6.76, and 0.64 microM against the growth of HeLa, SKHep, AGS, and A549 cells, respectively. Flowcytometric analysis indicated 22c can induce cell cycle arrest in S phase, and DNA polyploidy (>4n) followed by apoptosis.
Bioorganic & Medicinal Chemistry | 2004
Yeh-Long Chen; Hsien-Ming Hung; Chih-Ming Lu; Kuang‐Chieh Li; Cherng-Chyi Tzeng
European Journal of Medicinal Chemistry | 2005
Yue-Ling Zhao; Yeh-Long Chen; Feng-Shuo Chang; Cherng-Chyi Tzeng
European Journal of Medicinal Chemistry | 2005
Yeh-Long Chen; I.-Li Chen; Tai-Chi Wang; Chein-Hwa Han; Cherng-Chyi Tzeng
Biochemical Pharmacology | 2007
Meng-Wei Lin; Lo-Ti Tsao; Ling-Chu Chang; Ye-Long Chen; Li-Jiau Huang; Sheng-Chu Kuo; Cherng-Chyi Tzeng; Miau-Rong Lee; Jih-Pyang Wang
Bioorganic & Medicinal Chemistry | 2006
Yeh-Long Chen; Yue-Ling Zhao; Chih-Ming Lu; Cherng-Chyi Tzeng; Jih-Pyang Wang
Bioorganic & Medicinal Chemistry | 2004
Yeh-Long Chen; I-Li Chen; Chih-Ming Lu; Cherng-Chyi Tzeng; Lo-Ti Tsao; Jih-Pyang Wang
Bioorganic & Medicinal Chemistry | 2005
Tai-Chi Wang; I.-Li Chen; Pei Jung Lu; Chui-Hei Wong; Chang-Hui Liao; Kuei-Ching Tsiao; Ken-Ming Chang; Yeh-Long Chen; Cherng-Chyi Tzeng
Bioorganic & Medicinal Chemistry | 2005
Yue-Ling Zhao; Yeh-Long Chen; Jia-Yuh Sheu; I-Li Chen; Tai-Chi Wang; Cherng-Chyi Tzeng
Helvetica Chimica Acta | 2003
Yeh-Long Chen; Po-Hsu Chen; Chao-Ho Chung; Kuang‐Chieh Li; Haw‐Yaun Jeng; Cherng-Chyi Tzeng